Metabolic changes following subthalamotomy for advanced Parkinson's disease

Annals of Neurology

Volumn 50, Issue 4, 2001, Pages 514-520

  Su, Philip C ^a   Yilong, M ^a   Fukuda, Masafumi ^a   Mentis, Marc J ^a   Tseng, Ham Min ^a   Yen, Ruoh Fang ^a   Liu, Hon Man ^a   Moeller, J R ^a   Eidelberg, David ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE; SELEGILINE;

ADULT; ARTICLE; BRAIN MAPPING; BRAIN METABOLISM; CLINICAL ARTICLE; FEMALE; GLOBUS PALLIDUS; GLUCOSE UTILIZATION; HUMAN; MALE; MORBIDITY; MOTOR ACTIVITY; PARKINSON DISEASE; PONS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; THALAMOTOMY; THALAMUS;

ADULT; CEREBELLAR NUCLEI; FEMALE; FLUORODEOXYGLUCOSE F18; GLOBUS PALLIDUS; GLUCOSE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PONS; RADIOPHARMACEUTICALS; SUBTHALAMIC NUCLEUS; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0034785632     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1232     Document Type: Article

References (36)

1. Leksell's posteroven tral pallidotomy in the treatment of Parkinson's disease
2. Stereotactic ventral pallidotomy for Parkinson's disease
3. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study
4. Effect of GPi pallidotomy on motor function in Parkinson's disease
5. High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease
6. A hypothesis on the pathophysiological mechanisms that underlie levodopa-or dopamine agonist-induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment
7. Basal gangliathalamocortical circuits: Parallel substrates for motor, oculomotor, prefrontal and limbic functions
8. The primate subthalamic nucleus III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism
9. Functional and pathophysiological models of the basal ganglia
10. The pedunculopontine nucleus and Parkinson's disease
11. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
12. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate
13. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-exposed primate
14. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease
15. Bilateral subthalamic nucleotomy can be accomplished safely
16. Dorsal subthalamotomy for Parkinson's disease
17. Unilateral subthalamotomy in the treatment of advanced Parkinson's disease (PD)
18. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease
19. Preoperative indicators of clinical outcome following stereotaxic pallidotomy
20. Unified Parkinson's disease rating scale
21. Quantitative brain PET: Comparison of 2D and 3D acquisition on the GE Advance Scanner
22. Performance characteristics of a whole-body PET scanner
23. Metabolic correlates of pallidal neuronal activity in Parkinson's disease
24. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease
25. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: A PET study of resting-state glucose metabolism
26. The metabolic topography of parkinsonism
27. Reproducibility of regional metabolic covariance patterns: Comparison of four populations
28. Metabolic correlates of levodopa response in Parkinson's disease
29. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET
30. Functional brain networks in DYT1 dystonia
31. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry
32. Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation
33. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine
34. The pedunculopontine tegmental nucleus: Where the striatum meets the reticular formation
35. Organization of the nigrothalamocortical system in the rhesus monkey
36. Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space